Role of positron emission tomography computed tomography in carcinoma lung evaluation

Journal of Cancer Research and Therapeutics

Volumn 7, Issue 2, 2011, Pages 128-134

  Padma, S ^a   Sundaram, P Shanmuga ^a   George, Shamily ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

18 F fluoro deoxy glucose; Carcinoma lung; positron emission tomography computed tomography; staging and metastatic workup

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MEDRONATE TECHNETIUM TC 99M;

BRAIN METASTASIS; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISTANT METASTASIS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIVER METASTASIS; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREDICTIVE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 79960769593     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.82918     Document Type: Review

References (61)

1. Toomes H, Delphendahl A, Manke HG, Vogt-Moykopf I. The coin lesion of the lung. A review of 955 resected coin lesions. Cancer 1983;51:534-7. (Pubitemid 13185386)
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
3. Zerhouni EA, Stitik FP, Siegelman S, Sagel SS, Proto AV, Muhm JR, et al. CT of the pulmonary nodule: A cooperative study. Radiology 1986;160:319-27. (Pubitemid 16070633)
4. Allen MS, Deschamps C, Lee RE, Trastek VF, Daly RC, Pairolero PC Video-assisted thoracoscopic stapled wedge excision for indeterminate pulmonary nodules. J Thorac Cardiovasc Surg 1993;106:1048-52. (Pubitemid 24018547)
5. Knight SB, Delbeke D, Stewart JR, Sandler MP. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 1996;109:982-8. (Pubitemid 26113641)
6. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996;37:943-8. (Pubitemid 126447126)
7. Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998;16:1075-84. (Pubitemid 28108743)
8. Bakheet SM, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 1998;28:352-8. (Pubitemid 28478048)
9. Goo JM, Im JG, Do KH, Yeo JS, Seo JB, Kim HY. Pulmonary tuberculoma evaluated by means of FDG PET: Findings in 10 cases. Radiology 2000;216:117-21. (Pubitemid 30434730)
10. Wilkinson MD, Fulham MJ, Mc Caughan BC, Constable CJ. Invasive aspergillosis mimicking stage IIIA non-small-cell lung cancer on FDG positron emission tomography. Clin Nucl Med 2003;28:234-5. (Pubitemid 38281987)
11. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994;35:1647-9.
12. Midthun DE. Solitary pulmonary nodule: Time to think small. Curr Opin Pulm Med 2000;6:364-70. (Pubitemid 30469239)
13. Bousson V, Moretti JL, Weinmann P, Safi N, Tamgac F, Groiselle C, et al. Assessment of malignancy in pulmonary lesions: FDG dual-head coincidence gamma camera imaging in association with serum tumor marker measurement. J Nucl Med 2000;41:1801-7.
14. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr 1979;3:299-3081.
15. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995;60:1348-52.
16. Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J. FDG-PET imaging in lung cancer: how sensitive is it for bronchoalveolar carcinoma? Eur J Nucl Med Mol Imaging 2002;29:1166-73. (Pubitemid 34985361)
17. Erasmus JJ, Mc Adams HP, Patz EF Jr, Coleman RE, Ahuja V, Goodman PC Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol 1998;170:1369-73. (Pubitemid 28210961)
18. Gerard A, Silvestri GA, Gould MK, Margolis ML, Tanoue LT, Mc Crory D, et al. Noninvasive staging of non-small cell lung cancer: ACCP evidence-based clinical practice guidelines. 2nd ed. Chest 2007;132:178S-201.
19. Lowe VJ, Naunheim KS. Positron Emission Tomography in Lung Cancer. Ann Thorac Surg 1998;65:1821-9.
20. Nehmeh SA, Erdi YE, Pan T, Pevsner A, Rosenzweig KE, Yorke E, et al. Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys 2004;31:3179-86. (Pubitemid 40064969)
21. Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002;43:871-5. (Pubitemid 34747808)
22. Swensen SJ, Brown LR, Colby TV, Weaver AL. Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology 1995;194:393-8.
23. Swensen SJ, Viggiano RW, Midthun DE, Müller NL, Sherrick A, Yamashita K, et al. Lung nodule enhancement at CT: Multicenter study. Radiology 2000;214:73-80. (Pubitemid 30019872)
24. Yi CA, Lee KS, Kim BT, Choi JY, Kwon OJ, Kim H, et al. Tissue characterization of solitary pulmonary nodule: Comparative study between helical dynamic CT and integrated PET/CT. J Nucl Med 2006;47:443-50. (Pubitemid 46768487)
25. Feld R, Abratt R, Graziano S, Jassem J, Lacquet L, Ninane V, et al. Pretreatment minimal staging and prognostic factors for non-small cell lung cancer. Lung Cancer 1997;17:S3-10.
26. Padovani B, Mouroux J, Seksik L, Chanalet S, Sedat J, Rotomondo C, et al. Chest wall invasion by bronchogenic carcinoma: Evaluation with MR imaging. Radiology 1993;187:33-8. (Pubitemid 23097854)
27. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-7. (Pubitemid 36706537)
28. Erasmus JJ, Mc Adams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF. FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roentgenol 2000;175:245-9. (Pubitemid 30415572)
29. Gupta NC, Rogers JS, Graeber GM, Gregory JL, Waheed U, Mullet D, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. Chest 2002;122:1918-24. (Pubitemid 36051125)
30. Bruzzi J, Komaki R, Walsh G. Comprehensive review of superior sulcus tumors. Part II: Imaging initial staging, assessment of resectability and therapeutic response. Radiographics 2008;28:561-72.
31. Martini N, Kris MG, Ginsberg RJ. The role of multimodality therapy in locoregional non-small cell lung cancer. Surg Oncol Clin N Am 1997;6:769-91. (Pubitemid 27454671)
32. Bunyaviroch T, Coleman RE. PET evaluation of lung cancer. J Nucl Med 2006;47:451-69. (Pubitemid 46768488)
33. Van Schil PE, Van HR, Schoofs EL. The value of mediastinoscopy in preoperative staging of bronchogenic carcinoma. J Thorac Cardiovasc Surg 1989;97:240-4. (Pubitemid 19061427)
34. Rusch VW, Parekh KR, Leon L, Venkatraman E, Bains MS, Downey RJ, et al. Factors determining outcome after surgical resection of T3, T4 lung cancer of superior sulcus. J Thorac Cardiovasc Surg 2000;119:1147-53. (Pubitemid 30412611)
35. Birim O, Kappetein AP, Stijnen T, Bogers AJ. Meta analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg 2005;79:375-82. (Pubitemid 40037519)
36. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, et al. Non-small cell lung cancer: Dual-modality PET/CT in preoperative staging. Radiology 2003;229:526-33. (Pubitemid 37310842)
37. Shields TW. The significance of ipsilateral lymph node metastasis (N2 disease) in non small cell carcinoma of the lung: A commentary J Thorac Cardiovasc Surg 1990;99:48-53. (Pubitemid 20041513)
38. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994;191:371-7. (Pubitemid 24141035)
39. Poncelet AJ, Lonneux M, Coche E, Weynand B, Noirhomme P; Groupe d'Oncologie Thoracique des Cliniques Saint-Luc. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma. Eur J Cardiothorac Surg 2001;20:468-74.
40. Quint LE, Tummala S, Brisson LJ, Francis IR, Krupnick AS, Kazerooni EA, et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg 1996;62:246-50. (Pubitemid 26239872)
41. Erasmus JJ, Patz EF Jr, Mc Adams HP, Murray JG, Herndon J, Coleman RE, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 1997;168:1357-60.
42. Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998;25:1244-7. (Pubitemid 28446049)
43. Valk PE, Pounds TR, Hopkins DM, Haseman MK, Hofer GA, Greiss HB, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 1995;60:1573-81. (Pubitemid 26078244)
44. Saunders CA, Dussek JE, O'Doherty MJ, Maisey MN. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg 1999;67:790-7. (Pubitemid 29207699)
45. Schaffler GJ, Wolf G, Schoellnast H, Groell R, Maier A, Smolle-Jüttner FM, et al. Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET. Radiology 2004;231: 858-65. (Pubitemid 38668109)
46. Ferrigno D, Buccheri G. Cranial computed tomography as a part of the initial staging procedures for patients with non-small-cell lung cancer. Chest 1994;106:1025-9. (Pubitemid 24309535)
47. Reed CE, Harpole DH, Posther KE, Woolson SL, Downey RJ, Meyers BF, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: The utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 2003;126:1943-51. (Pubitemid 38020756)
48. Eschmann SM, Friedel G, Paulsen F, Reimold M, Hehr T, Budach W, et al. 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2007;34:463-71. (Pubitemid 46426996)
49. Bury T, Corhay JL, Duysinx B, Daenen F, Ghaye B, Barthelemy N, et al. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 1999;14:1376-80. (Pubitemid 30019536)
50. Frank A, Lefkowitz D, Jaeger S, Gobar L, Sunderland J, Gupta N, et al. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. Int J Radiat Oncol Biol Phys 1995;32:1495-512.
51. Lowe VJ, Hebert ME, Hawk TC. Chest wall FDG accumulation in serial FDG-PET images in patients being treated for bronchogenic carcinoma with radiation. J Nucl Med 1994;35:76P.
52. Dunagan D, Chin R Jr, Mc Cain T, Case L, Harkness B, Oaks T, et al. Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer. Chest 2001;119:333-9. (Pubitemid 32163740)
53. Ahuja V, Coleman RE, Herndon J, Patz EF Jr. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. Cancer 1998;83:918-24. (Pubitemid 28401925)
54. Dhital K, Saunders CA, Seed PT, O'Doherty MJ, Dussek J. 18F-Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg 2000;18: 425-8.
55. Janne PA, Freidlin B, Saxman S, Johnson DH, Livingston RB, Shepherd FA, et al. Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America. Cancer 2002;95:1528-38.
56. Darling GE. Staging of the patient with small cell lung cancer. Chest Surg Clin N Am 1997;7:81-94. (Pubitemid 27030148)
57. Jelinek JS, Redmond J, Perry JJ, Burrell LM, Benedikt RA, Geyer CA. Small cell lung cancer: Staging with MR imaging. Radiology 1990;177:837-42.
58. th ed. Philadelphia: JB Lippincott; 1995. p. 115.
59. Stitik FP. The new staging of lung cancer. Radiol Clin North Am 1994;32:635-47. (Pubitemid 24219899)
60. De Ruysscher, Kirsch CM. PET scans in radiotherapy planning of lung cancers. Radiother Oncol 2010;96;335-8.
61. IAEA - TECDOC Role of PET/CT in radiotherapy planning for Cancer patient treatment planning 2008. p. 1603.